Why the study?
Although many factors contribute to primary idiopathic complete atrioventricular block (iCAVB), the relationship between whole blood viscosity and iCAVB had not been clarified.
Is increased whole blood viscosity associated with primary idiopathic complete atrioventricular block and all-cause mortality?
Is increased whole blood viscosity associated with primary idiopathic complete atrioventricular block and all-cause mortality?
Increased whole blood viscosity is an independent predictor of primary idiopathic complete atrioventricular block and is associated with higher all-cause mortality in these patients.
Elevated WBV may flag iCAVB risk and poorer outcomes; leaves open whether viscosity modulation affects conduction disease.
BACKGROUND: Complete atrioventricular block is most commonly caused by age-related degeneration and fibrosis in the cardiac conduction system and is called primary idiopathic complete atrioventricular (iCAVB). Although many factors affect this situation, which increases with age in the cardiac conduction system, the relationship between whole blood viscosity (WBV) and iCAVB has not been clarified until now. In this study, we aim to reveal the relationship between iCAVB and WBV. METHODS AND RESULTS: 141 patients with dual-chamber permanent pacemaker implanted for iCAVB and 140 age- and sex-matched subjects were included in this study. The WBV values of the study groups were compared in both high shear rate (HSR) and low shear rate (LSR). Both WBV at HSR and WBV at LSR were significantly higher in the iCAVB group compared to the control group (16.11 [15.14-16.89] vs 14.40 [13.62-15.58]; 39.82 [17.43-55.23] vs 1.38 [-13.14-26.73]; p < 0.001, respectively). The patient population was followed up for an median of 38 months for all-cause mortality. Higher mortality rates were found in higher WBV at HSR and WBV at LSR (p < 0.001,for both). CONCLUSIONS: In this study, WBV was found to be an independent predictor for iCAVB, and in these patients WBV was associated with poor clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Toprak et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: